Dianthus Other Current Liab vs Common Stock Shares Outstanding Analysis

DNTH Stock   23.99  0.16  0.67%   
Dianthus Therapeutics financial indicator trend analysis is much more than just examining Dianthus Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dianthus Therapeutics is a good investment. Please check the relationship between Dianthus Therapeutics Other Current Liab and its Common Stock Shares Outstanding accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dianthus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Dianthus Stock please use our How to Invest in Dianthus Therapeutics guide.

Other Current Liab vs Common Stock Shares Outstanding

Other Current Liab vs Common Stock Shares Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dianthus Therapeutics Other Current Liab account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have very week relationship.
The correlation between Dianthus Therapeutics' Other Current Liab and Common Stock Shares Outstanding is 0.29. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Dianthus Therapeutics, assuming nothing else is changed. The correlation between historical values of Dianthus Therapeutics' Other Current Liab and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of Dianthus Therapeutics are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Other Current Liab i.e., Dianthus Therapeutics' Other Current Liab and Common Stock Shares Outstanding go up and down completely randomly.

Correlation Coefficient

0.29
Relationship DirectionPositive 
Relationship StrengthVery Weak

Other Current Liab

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.
Most indicators from Dianthus Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dianthus Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dianthus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Dianthus Stock please use our How to Invest in Dianthus Therapeutics guide.As of now, Dianthus Therapeutics' Sales General And Administrative To Revenue is increasing as compared to previous years. The Dianthus Therapeutics' current Enterprise Value Over EBITDA is estimated to increase to 1.70, while Selling General Administrative is projected to decrease to under 14.9 M.
 2021 2023 2024 (projected)
Interest Expense3.6M4.1M2.7M
Depreciation And Amortization2.0M355K337.3K

Dianthus Therapeutics fundamental ratios Correlations

0.890.940.870.67-0.82-0.850.730.80.781.0-0.770.330.970.560.21.00.470.60.54-0.260.06-0.420.460.450.43
0.890.980.690.75-0.68-0.830.550.660.770.89-0.790.290.920.620.390.880.710.490.52-0.320.26-0.380.360.260.37
0.940.980.760.76-0.71-0.880.690.70.810.94-0.780.290.950.660.330.930.670.520.52-0.30.19-0.380.370.310.37
0.870.690.760.55-0.9-0.760.740.890.680.86-0.790.170.880.59-0.250.860.120.650.42-0.18-0.38-0.260.260.650.23
0.670.750.760.55-0.31-0.890.620.280.870.65-0.45-0.130.750.510.050.650.450.45-0.030.28-0.060.19-0.18-0.14-0.19
-0.82-0.68-0.71-0.9-0.310.59-0.47-1.0-0.4-0.840.83-0.5-0.8-0.490.04-0.83-0.15-0.64-0.720.510.160.59-0.59-0.85-0.56
-0.85-0.83-0.88-0.76-0.890.59-0.76-0.57-0.84-0.840.67-0.12-0.85-0.64-0.1-0.84-0.53-0.45-0.28-0.030.030.11-0.1-0.18-0.1
0.730.550.690.740.62-0.47-0.760.460.770.71-0.42-0.020.70.6-0.130.710.310.370.160.05-0.24-0.020.040.250.01
0.80.660.70.890.28-1.0-0.570.460.370.81-0.820.490.780.48-0.040.810.140.640.73-0.52-0.15-0.610.590.860.57
0.780.770.810.680.87-0.4-0.840.770.370.75-0.55-0.270.810.550.010.750.460.38-0.040.25-0.110.16-0.15-0.08-0.16
1.00.890.940.860.65-0.84-0.840.710.810.75-0.790.360.970.560.21.00.480.590.56-0.290.06-0.440.490.470.45
-0.77-0.79-0.78-0.79-0.450.830.67-0.42-0.82-0.55-0.79-0.36-0.79-0.790.01-0.77-0.47-0.26-0.480.490.130.3-0.29-0.54-0.27
0.330.290.290.17-0.13-0.5-0.12-0.020.49-0.270.36-0.360.270.260.40.360.330.140.82-0.850.37-0.750.850.610.79
0.970.920.950.880.75-0.8-0.850.70.780.810.97-0.790.270.620.10.960.450.650.46-0.24-0.04-0.310.350.420.32
0.560.620.660.590.51-0.49-0.640.60.480.550.56-0.790.260.62-0.120.550.58-0.030.21-0.4-0.230.04-0.010.29-0.05
0.20.390.33-0.250.050.04-0.1-0.13-0.040.010.20.010.40.1-0.120.210.7-0.050.5-0.370.99-0.60.56-0.180.63
1.00.880.930.860.65-0.83-0.840.710.810.751.0-0.770.360.960.550.210.470.60.56-0.290.07-0.440.490.470.46
0.470.710.670.120.45-0.15-0.530.310.140.460.48-0.470.330.450.580.70.47-0.180.36-0.40.63-0.270.25-0.150.29
0.60.490.520.650.45-0.64-0.450.370.640.380.59-0.260.140.65-0.03-0.050.6-0.180.420.0-0.13-0.380.370.50.37
0.540.520.520.42-0.03-0.72-0.280.160.73-0.040.56-0.480.820.460.210.50.560.360.42-0.80.44-0.960.920.760.95
-0.26-0.32-0.3-0.180.280.51-0.030.05-0.520.25-0.290.49-0.85-0.24-0.4-0.37-0.29-0.40.0-0.8-0.330.73-0.75-0.65-0.73
0.060.260.19-0.38-0.060.160.03-0.24-0.15-0.110.060.130.37-0.04-0.230.990.070.63-0.130.44-0.33-0.560.52-0.240.59
-0.42-0.38-0.38-0.260.190.590.11-0.02-0.610.16-0.440.3-0.75-0.310.04-0.6-0.44-0.27-0.38-0.960.73-0.56-0.95-0.66-0.99
0.460.360.370.26-0.18-0.59-0.10.040.59-0.150.49-0.290.850.35-0.010.560.490.250.370.92-0.750.52-0.950.640.98
0.450.260.310.65-0.14-0.85-0.180.250.86-0.080.47-0.540.610.420.29-0.180.47-0.150.50.76-0.65-0.24-0.660.640.62
0.430.370.370.23-0.19-0.56-0.10.010.57-0.160.45-0.270.790.32-0.050.630.460.290.370.95-0.730.59-0.990.980.62
Click cells to compare fundamentals

Dianthus Therapeutics Account Relationship Matchups

Dianthus Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets161.5M161.6M9.5M83.1M179.4M112.5M
Other Current Liab11.3M7.7M4.0M6.6M6.1M6.5M
Total Current Liabilities14.1M11.4M5.4M8.2M9.6M9.0M
Total Stockholder Equity141.2M143.9M(17.2M)(44.4M)168.9M177.3M
Property Plant And Equipment Net9.9M8.3M33K956K800K760K
Net Debt(65.1M)(58.2M)(7.6M)(14.6M)(131.7M)(125.2M)
Retained Earnings(179.5M)(254.4M)(17.4M)(45.9M)(89.4M)(93.9M)
Accounts Payable2.8M3.8M1.4M1.2M2.6M2.3M
Cash65.1M58.2M7.6M15.4M132.3M138.9M
Non Current Assets Total11.7M10.1M63K1.1M2.0M1.9M
Cash And Short Term Investments145.7M148.8M7.6M75.5M173.7M103.1M
Common Stock Shares Outstanding2.3M2.7M3.4M3.7M5.2M3.2M
Liabilities And Stockholders Equity161.5M161.6M9.5M83.1M179.4M112.5M
Other Current Assets4.1M2.7M274K905K3.3M2.1M
Other Stockholder Equity320.6M398.3M498.3M(116.4M)258.2M221.6M
Total Liab20.3M17.7M26.7M127.5M10.5M10.0M
Total Current Assets149.8M151.5M9.4M82.0M177.5M107.1M
Accumulated Other Comprehensive Income8K(23K)(30K)(161K)47K49.4K
Common Stock39K49K59K61K15K14.3K
Non Currrent Assets Other1.8M1.0(1.8M)61K1.1M1.1M
Short Term Investments80.7M90.7M45.3M60.1M41.4M53.6M
Non Current Liabilities Total6.2M6.3M21.3M119.3M904K858.8K

Currently Active Assets on Macroaxis

When determining whether Dianthus Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dianthus Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dianthus Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dianthus Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dianthus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Dianthus Stock please use our How to Invest in Dianthus Therapeutics guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dianthus Therapeutics. If investors know Dianthus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dianthus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
7.22
Revenue Per Share
0.19
Quarterly Revenue Growth
1.351
Return On Assets
(0.19)
Return On Equity
(0.26)
The market value of Dianthus Therapeutics is measured differently than its book value, which is the value of Dianthus that is recorded on the company's balance sheet. Investors also form their own opinion of Dianthus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dianthus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dianthus Therapeutics' market value can be influenced by many factors that don't directly affect Dianthus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dianthus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dianthus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dianthus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.